Novo Nordisk To Axe 1,000 Jobs In Cost-Cutting Drive

Copenhagen: The world's largest insulin maker, Novo Nordisk, is cutting 1,000 jobs as a part of a plan to reduce costs as it faces a challenging environment in 2017, especially in the large U.S. market, the company said on Thursday. The Danish company, which has a global workforce of 42,300, said about 500 of the lay-offs would be in Denmark. The headcount reduction and associated costs would not change the financial outlook for 201...